What is being tested?The HPV test is looking for evidence of infection by high-risk types of human papillomavirus (HPV). HPV is a group of about 100 related
viruses that cause skin warts and genital warts (also called condylomata). Common in young men and women, most HPV infections are short-lived and relatively
benign. A few types of HPV (such as HPV-16, HPV-18, HPV-31, and HPV-45), however, are considered high-risk. They do not usually cause visible warts, but they are persistent and have been linked to
cervical, penile, anal, and other forms of cancer. Traditionally, HPV infection has been detected as abnormal cell changes on a
Pap smear, a test used primarily to detect cancer of the cervix (the lower part of the uterus or womb) or conditions that may lead to cancer. During a Pap smear, the “normalness” of cervical cells is evaluated under a microscope. “Low-grade” changes to the cells on a Pap smear may indicate an HPV infection, but there is no clear distinction between high- and low-risk types.
A recently developed DNA test for HPV is gaining widespread acceptance as an additional cervical cancer screening tool and as a follow-up test to abnormal changes on a Pap smear. It uses the same cervical sample as the Pap smear to detect and confirm the presence of high-risk types of HPV; it tests for the 13 most common types of high-risk HPV but does not distinguish between them. If there is a need, further DNA testing can be done by another method to determine exactly which type(s) of HPV are present, although this is not frequently done.